Topical Drug Delivery Market (By Product: Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products; By Route of Administration: Oral, Injectable, Dermal, Ocular, Pulmonary, Implantable, Transmucosal, Nasal; By End User: Home Care Settings, Hospitals & Clinics, Burn Centers, Other Facilities) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2032
The global topical drug delivery market was estimated at US$ 100 billion in 2022 and is expected to hit around US$ 186.83 billion by 2032, poised to grow at a CAGR of 6.50% from 2023 to 2032.
To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics
The U.S. topical drug delivery market was valued at US$ 23.10 billion in 2022 and is projected to grow around US$ 42.75 billion by 2032, at a CAGR of 6.40% from 2023 to 2032.
Geographically, the largest topical drug delivery market share was held by North America, primarily because of the presence of large number of pharmaceutical companies. The Asia-Pacific (APAC) region is anticipated to grow at the fastest pace in the coming times. The reasons for this are the rising healthcare expenditure, adding focus of pharmaceutical companies in the market in developing countries, growing senior population, and surging disposable income.
Key factors that propels the topical drug delivery market includes burn injuries and high frequency of skin conditions, deep drugs penetration in human body, surge in preference towards topical drug delivery owing to its nature of non-invasiveness, and surge in senior population. Factors similar as biologics deliveries via the transversal route and accession of small key players are anticipated to present myriad opportunities for market growth in near future.
According to the Disease Project of Global Burden, various skin diseases like eczema, psoriasis, vitiligo and skin cancer continue to be the major and leading cause of nonfatal disease burden around the globe and thus further affect a large proportion of the global population. As per the data of WHO, 0.1 million of melanoma skin cancer cases and in between of 2 to 3 million of non-melanoma skin cancer cases are diagnosed every year across the globe. In addition, the occurrence of psoriasis around the world ranges from 0.1% to 11.5%, which is making it a major problem around the world with at least 100 million individuals affected worldwide. Therefore, the demand for advanced topical products is likely to boost in the forthcoming years.
| Report Coverage | Details |
| Market Size | USD 186.83 Billion by 2032 |
| Growth Rate | CAGR of 6.50% from 2023 to 2032 |
| Base Year | 2022 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Product, By Route of Administration, and By End User |
| Companies Mentioned | Johnson & Johnson, Novartis International AG, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, Antares Pharma, Inc., GlaxoSmithKline plc, 3M (US), Merck & Co., Inc., Sanofi, Amgen, Inc. |
The growing frequency of diabetes is a crucial driving factor for the topical drug delivery market growth. As per the World Health Organization, the number of people suffering from diabetes rose from 108 million in 1980 to 422 million in 2014. Likewise, roughly1.6 million deaths were caused by diabetes in 2016. Diabetes is a habitual complaint which occurs if the body cannot use the insulin it produces effectively or if the pancreas doesn't produce enough insulin. Since topical drugs are used considerably for treating diabetic neuropathic pain and bottom ulcers, their demand is adding with the growing frequency of diabetes.
Due to the rapid spread of COVID-19 and adding fear, drugs are being grazed by various patients and end users. This is anticipated to boost the growth of the market during 2020-2021. Various companies have witnessed an increase in profit in the first quarter of 2020 as compared to the first quarter of 2019. For illustration, AbbVie reported an increase of16.8% in its profit in the first quarter of 2020 as compared to the first quarter of 2019.
Raw material needed for manufacturing drugs, similar as drug component and equipment used in manufacturing, are at the threat of a supply shortage owing to the temporary lockdown of manufacturing hubs in areas affected by COVID-19 or travel restrictions impacting shipments. Still, presently, the trading and import of raw material has proceeded back owing to the uplifting of lockdowns and proceeded manufacturing and product of pharmaceutical companies.
The disruption caused by the COVID-19 has handicapped the global market considerably, performing in various problems in the supply chain of a various essentials, but the epidemic has caused a rise in the sector of healthcare majorly among the pharmaceutical industry. In addition, key players around the world are going through from cancellations of event and are preventing pharmaceutical companies from introducing new services and products. In addition, digitalization in the world of pharmaceutical incorporated literacy into unborn extremity processes and plans.
The semi-solid formulation segment dominated the topical drug delivery market in 2023. Semi-solid formulations are important in the topical drug delivery market. Among these compositions are lotions, ointments, gels, and creams. Their versatility in treating a range of dermatological problems, ease of administration, and capacity to transfer active substances straight to the skin make them attractive. its effectiveness in localized treatment, patient compliance, and non-invasiveness are the main aspects that have contributed to its popularity. Their notable presence in dermatology and other therapeutic fields is largely due to advancements in formulation technology, which continue to improve their stability, bioavailability, and therapeutic efficacy.
The solid formulation segment is expected to be a fastest growing during the forecast period. Solid formulations are essential in the topical drug delivery market because of their application simplicity, stability, and convenience. Creams, ointments, gels, powders, and solid sticks (like lip balms) are some examples of these formulations. Because they can administer medications directly to the skin, where they can act locally or be absorbed systemically, they are favored. Solid formulations are useful for a variety of therapeutic applications in dermatology, pain treatment, and other fields because they preserve drug potency, lower the danger of contamination, and provide regulated release patterns.
The dermal segment dominated the topical drug delivery market in 2023. The application of pharmaceuticals or remedies directly into the skin is referred to as the dermal mode of administration in the topical drug delivery market. This technique enables the transdermal administration of drugs into the bloodstream for systemic effects as well as the localized treatment of skin diseases like dermatitis, psoriasis, and eczema. Creams, gels, ointments, patches, and sprays are examples of dermal formulations; all are intended to maximize medication absorption through the skin while reducing systemic side effects. This section is influenced by a number of factors, such as skin penetration enhancers, formulation technology, and the particular therapeutic goals of the medicine being administered.
The retail pharmacies segment dominated the topical drug delivery market in 2023. In the topical drug delivery market, the retail pharmacies segment is essential for providing customers with direct access to topical pharmaceuticals. A large selection of topical formulations, such as creams, ointments, gels, lotions, and patches, are easily accessible at these pharmacies. Retail pharmacists can offer helpful advice and information on topical medicine use, ensuring correct administration and adherence to treatment plans. It's a convenient one-stop shop for all healthcare needs because patients may pick up their prescriptions together with other health-related products. A prescription is sometimes needed for many topical treatments, and retail pharmacies make it easier and faster to complete these prescriptions.
nline pharmacies are expected to be a fastest growing market. For a number of reasons, the topical drug delivery market's online pharmacies segment is growing in importance. Accessible and convenient, a large assortment of topical drugs and formulations are offered by online pharmacies. They provide competitive pricing and discounts to meet the growing demand for digital health services from consumers. Additionally, internet pharmacies frequently offer thorough product details and client testimonials, which boosts consumer confidence when buying topical medication delivery items online. This market is predicted to keep expanding as digital health services become more widely available worldwide.
Key Market Developments
The Topical drug delivery market is highly fragmented with the presence of several local and global companies. These key players are highly determined to gain huge market share by adopting various strategies, such as partnerships, investments, mergers and acquisition. Companies are also spending on the development of improved products. Moreover, these players are further focusing on maintaining pricing which is competitive in nature.
Recognizing the potential for biologics manufacturing, companies, such as Evonik (Germany), have made several strategic developments. Furthermore, the company also raised its capacity of production by acquiring SurModics in the year 2021, which majorly focuses on parenteral applications of controlled-release. In addition, the key player named Evonik acquired a various complementary technologies, such as BoehringerIngelheim’s RESOMER platform, in order to improve its ability in this market.
Similarly, in 2019, the key player named WuXi Biologics declared the launch of its WuXi Vaccines, which is a joint venture with the company named ShanghaiHile Bio-Technology Co., Ltd. In addition, this companies entered into the partnership based strategy under which WuXi Vaccines will build a dedicated facility and thus supply a commercial global market product. In addition, the biopharmaceutical industry has further foreseen the emergence of a new level of therapeutics, presenting significant potential in diabetes, oncology new treatments, and other disease areas.
Segments Covered in the Report
By Product
By Route of Administration
By End User
By Geography
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
